News from the 17th AACR-NCI-EORTC Conference.
In: Inpharma Weekly, 2006-01-07, Heft 1519, S. 8-9
serialPeriodical
Zugriff:
The article discusses research on the benefits of adding cetuximab, an IgG1 monoclonal antibody, to standard radiotherapy in the treatment of a variety of cancers. It references a study by J. A. Bonner, P. M. Harari, J. Giralt, N. Azamia, R. B. Cohen, C. Jones, R. Sur, D. Raben, J. Baselga, S. Spencer, N. Amellal, E. Rowinsky and K. K. Ang, which was presented during the 17th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
Titel: |
News from the 17th AACR-NCI-EORTC Conference.
|
---|---|
Zeitschrift: | Inpharma Weekly, 2006-01-07, Heft 1519, S. 8-9 |
Veröffentlichung: | 2006 |
Medientyp: | serialPeriodical |
ISSN: | 1173-8324 (print) |
DOI: | 10.2165/00128413-200615190-00018 |
Schlagwort: |
|
Sonstiges: |
|